신일제약

012790KOSDAQ

64.0 / 100

Reference Date: 2026-10-23

Financial Score26.5 / 40

News Sentiment12.5 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Rose 5.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Shinil Pharmaceutical, established in 1971, specializes in the production and sale of various pharmaceuticals such as tablets, capsules, and ointments, while also operating a CDMO business. The company diversifies its operations through the 'Pamtree' brand, offering functional cosmetics and health supplements, alongside revenue from medical devices and real estate rentals.

Number of Employees

413people

Average Salary

49.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.72Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

0.50Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

5.04Industry Average 8.002.5Point

Below industry avg

Debt Ratio

1.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼21.3% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 8.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position8.0Point

Near 52w high (88%, uptrend)

Current 6,330Won52-week high 6,52052-week low 4,900

1-month return4.0Point

1m +5.15% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral기업가치제고계획(자율공시) (PBR 개선 계획 제출 기업)2026-10-22